| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Disasters | 21 | 2011 | 204 | 4.370 |
Why?
|
| Electronic Health Records | 19 | 2023 | 374 | 4.120 |
Why?
|
| Emergency Medical Service Communication Systems | 15 | 2011 | 25 | 3.510 |
Why?
|
| Natural Language Processing | 11 | 2022 | 69 | 2.990 |
Why?
|
| Internet | 26 | 2013 | 390 | 2.630 |
Why?
|
| Data Warehousing | 4 | 2022 | 21 | 2.540 |
Why?
|
| Emergency Medical Services | 14 | 2007 | 225 | 2.530 |
Why?
|
| Software | 26 | 2020 | 418 | 2.250 |
Why?
|
| Information Storage and Retrieval | 6 | 2020 | 49 | 2.170 |
Why?
|
| Information Dissemination | 8 | 2022 | 113 | 2.090 |
Why?
|
| Rescue Work | 11 | 2007 | 17 | 1.710 |
Why?
|
| Decision Support Techniques | 17 | 2008 | 191 | 1.650 |
Why?
|
| Medical Informatics | 3 | 2022 | 71 | 1.540 |
Why?
|
| Computer Communication Networks | 9 | 2006 | 28 | 1.500 |
Why?
|
| Quality of Life | 30 | 2008 | 1515 | 1.460 |
Why?
|
| Medical Records | 5 | 2020 | 121 | 1.430 |
Why?
|
| Attitude to Health | 12 | 2003 | 403 | 1.340 |
Why?
|
| Schizophrenia | 11 | 2005 | 206 | 1.240 |
Why?
|
| Documentation | 4 | 2017 | 83 | 1.220 |
Why?
|
| Public Health Administration | 3 | 2021 | 36 | 1.190 |
Why?
|
| Humans | 127 | 2023 | 68618 | 1.180 |
Why?
|
| Telecommunications | 10 | 2013 | 31 | 1.170 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 143 | 1.170 |
Why?
|
| Health Information Interoperability | 3 | 2021 | 6 | 1.170 |
Why?
|
| Telemedicine | 7 | 2020 | 700 | 1.160 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 154 | 1.160 |
Why?
|
| Biomedical Research | 2 | 2021 | 310 | 1.050 |
Why?
|
| Information Systems | 6 | 2012 | 45 | 1.010 |
Why?
|
| Medical Informatics Applications | 4 | 2019 | 22 | 0.960 |
Why?
|
| Health Information Exchange | 3 | 2020 | 37 | 0.960 |
Why?
|
| Communication | 3 | 2015 | 329 | 0.900 |
Why?
|
| Biological Specimen Banks | 2 | 2021 | 38 | 0.880 |
Why?
|
| Public Health Informatics | 2 | 2021 | 7 | 0.870 |
Why?
|
| Systems Integration | 6 | 2021 | 30 | 0.850 |
Why?
|
| Pandemics | 3 | 2020 | 352 | 0.830 |
Why?
|
| Telemetry | 4 | 2006 | 23 | 0.830 |
Why?
|
| Drug Overdose | 1 | 2023 | 67 | 0.820 |
Why?
|
| Health Status Indicators | 6 | 2004 | 117 | 0.820 |
Why?
|
| Betacoronavirus | 2 | 2020 | 116 | 0.810 |
Why?
|
| Patient Identification Systems | 5 | 2021 | 18 | 0.800 |
Why?
|
| Opioid-Related Disorders | 2 | 2023 | 298 | 0.790 |
Why?
|
| Artificial Intelligence | 2 | 2020 | 159 | 0.770 |
Why?
|
| Intersectoral Collaboration | 1 | 2021 | 27 | 0.760 |
Why?
|
| Laboratories | 1 | 2021 | 44 | 0.760 |
Why?
|
| Mass Casualty Incidents | 2 | 2011 | 38 | 0.750 |
Why?
|
| Surveys and Questionnaires | 17 | 2021 | 2800 | 0.750 |
Why?
|
| Patient Participation | 8 | 2020 | 146 | 0.740 |
Why?
|
| Confidentiality | 2 | 2020 | 62 | 0.740 |
Why?
|
| Choice Behavior | 4 | 2004 | 85 | 0.740 |
Why?
|
| Continuity of Patient Care | 3 | 2020 | 170 | 0.730 |
Why?
|
| Public Health | 2 | 2021 | 201 | 0.720 |
Why?
|
| Physician-Patient Relations | 3 | 2015 | 261 | 0.710 |
Why?
|
| User-Computer Interface | 12 | 2014 | 230 | 0.710 |
Why?
|
| Government Regulation | 1 | 2020 | 46 | 0.710 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2020 | 148 | 0.710 |
Why?
|
| Phenotype | 2 | 2021 | 947 | 0.700 |
Why?
|
| Health Information Systems | 3 | 2020 | 18 | 0.690 |
Why?
|
| Health Status | 14 | 2008 | 429 | 0.660 |
Why?
|
| Support Vector Machine | 1 | 2019 | 15 | 0.660 |
Why?
|
| Brain Infarction | 1 | 2019 | 54 | 0.640 |
Why?
|
| Databases, Factual | 3 | 2021 | 622 | 0.630 |
Why?
|
| Triage | 4 | 2011 | 109 | 0.620 |
Why?
|
| Disaster Planning | 7 | 2011 | 105 | 0.610 |
Why?
|
| Antipsychotic Agents | 7 | 2005 | 247 | 0.610 |
Why?
|
| Smoking Cessation | 5 | 2023 | 1034 | 0.610 |
Why?
|
| Arthritis, Rheumatoid | 5 | 2007 | 157 | 0.610 |
Why?
|
| Patient Handoff | 2 | 2015 | 10 | 0.600 |
Why?
|
| Delivery of Health Care | 2 | 2021 | 445 | 0.590 |
Why?
|
| Accidental Falls | 1 | 2018 | 84 | 0.580 |
Why?
|
| Cost-Benefit Analysis | 10 | 2003 | 504 | 0.570 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 237 | 0.560 |
Why?
|
| Models, Organizational | 2 | 2014 | 97 | 0.560 |
Why?
|
| Awareness | 1 | 2017 | 81 | 0.550 |
Why?
|
| Medical Records Systems, Computerized | 5 | 2008 | 130 | 0.550 |
Why?
|
| Ethics Committees, Research | 1 | 2016 | 22 | 0.520 |
Why?
|
| Emergency Service, Hospital | 5 | 2023 | 711 | 0.520 |
Why?
|
| Risk Assessment | 2 | 2020 | 2007 | 0.510 |
Why?
|
| Oximetry | 2 | 2006 | 29 | 0.510 |
Why?
|
| Computer Systems | 9 | 2011 | 42 | 0.510 |
Why?
|
| Schizophrenic Psychology | 4 | 2004 | 53 | 0.500 |
Why?
|
| Decision Support Systems, Clinical | 3 | 2004 | 88 | 0.500 |
Why?
|
| Patient Satisfaction | 6 | 2014 | 378 | 0.500 |
Why?
|
| Learning | 1 | 2017 | 186 | 0.500 |
Why?
|
| Adult | 39 | 2023 | 21403 | 0.490 |
Why?
|
| Decision Making, Organizational | 1 | 2014 | 23 | 0.480 |
Why?
|
| Geographic Information Systems | 4 | 2007 | 34 | 0.480 |
Why?
|
| Multimedia | 6 | 2000 | 15 | 0.480 |
Why?
|
| Patient Discharge Summaries | 1 | 2014 | 1 | 0.470 |
Why?
|
| Patient Education as Topic | 8 | 2014 | 425 | 0.470 |
Why?
|
| Quality-Adjusted Life Years | 7 | 2008 | 106 | 0.460 |
Why?
|
| Male | 48 | 2023 | 37321 | 0.460 |
Why?
|
| Electronic Mail | 2 | 2004 | 29 | 0.450 |
Why?
|
| Patient Discharge | 1 | 2015 | 294 | 0.440 |
Why?
|
| Physicians | 1 | 2017 | 324 | 0.440 |
Why?
|
| United States | 20 | 2023 | 7367 | 0.430 |
Why?
|
| Models, Theoretical | 1 | 2016 | 384 | 0.430 |
Why?
|
| Algorithms | 9 | 2020 | 1196 | 0.430 |
Why?
|
| Middle Aged | 36 | 2023 | 21147 | 0.420 |
Why?
|
| Female | 43 | 2023 | 38074 | 0.410 |
Why?
|
| Internship and Residency | 2 | 2015 | 596 | 0.410 |
Why?
|
| American Recovery and Reinvestment Act | 1 | 2012 | 7 | 0.410 |
Why?
|
| National Health Programs | 1 | 2012 | 11 | 0.410 |
Why?
|
| Drug Therapy, Computer-Assisted | 5 | 1993 | 12 | 0.400 |
Why?
|
| Migraine Disorders | 2 | 2003 | 66 | 0.390 |
Why?
|
| Community Networks | 1 | 2012 | 96 | 0.380 |
Why?
|
| Clinical Trials as Topic | 5 | 2019 | 848 | 0.370 |
Why?
|
| Medical Record Linkage | 3 | 2016 | 42 | 0.370 |
Why?
|
| Microcomputers | 4 | 2014 | 32 | 0.360 |
Why?
|
| Population Surveillance | 1 | 2012 | 285 | 0.350 |
Why?
|
| Organizational Objectives | 1 | 2010 | 70 | 0.350 |
Why?
|
| Narration | 2 | 2020 | 29 | 0.340 |
Why?
|
| Feasibility Studies | 8 | 2006 | 652 | 0.330 |
Why?
|
| Decision Making, Computer-Assisted | 6 | 2000 | 18 | 0.330 |
Why?
|
| Colitis, Ulcerative | 3 | 1999 | 53 | 0.330 |
Why?
|
| Data Collection | 2 | 2003 | 420 | 0.320 |
Why?
|
| Mass Screening | 5 | 2023 | 843 | 0.320 |
Why?
|
| Depression | 5 | 2004 | 943 | 0.320 |
Why?
|
| Terrorism | 2 | 2005 | 21 | 0.310 |
Why?
|
| Computers | 3 | 2007 | 63 | 0.300 |
Why?
|
| Decision Making | 4 | 2008 | 410 | 0.300 |
Why?
|
| Health Surveys | 5 | 2004 | 489 | 0.300 |
Why?
|
| Reproducibility of Results | 11 | 2004 | 2077 | 0.290 |
Why?
|
| Depressive Disorder | 3 | 2001 | 621 | 0.290 |
Why?
|
| Rheumatology | 1 | 2007 | 46 | 0.280 |
Why?
|
| Prostatic Hyperplasia | 4 | 1999 | 25 | 0.280 |
Why?
|
| Interviews as Topic | 3 | 1997 | 392 | 0.280 |
Why?
|
| Markov Chains | 2 | 1997 | 133 | 0.280 |
Why?
|
| Aged | 19 | 2019 | 14862 | 0.280 |
Why?
|
| Sickness Impact Profile | 2 | 2005 | 27 | 0.280 |
Why?
|
| Medical Overuse | 2 | 2016 | 28 | 0.270 |
Why?
|
| Bias | 3 | 2003 | 148 | 0.270 |
Why?
|
| Pilot Projects | 5 | 2021 | 1342 | 0.260 |
Why?
|
| Video Recording | 3 | 2014 | 145 | 0.260 |
Why?
|
| Consumer Behavior | 3 | 2003 | 68 | 0.260 |
Why?
|
| Computers, Handheld | 1 | 2006 | 44 | 0.260 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2006 | 40 | 0.260 |
Why?
|
| Hospital Administration | 1 | 2006 | 43 | 0.260 |
Why?
|
| Risperidone | 1 | 2005 | 48 | 0.250 |
Why?
|
| Radio Waves | 1 | 2005 | 21 | 0.250 |
Why?
|
| Psychology, Adolescent | 1 | 2004 | 38 | 0.250 |
Why?
|
| Treatment Outcome | 8 | 2023 | 7029 | 0.250 |
Why?
|
| Geography | 1 | 2005 | 80 | 0.240 |
Why?
|
| Patient Preference | 2 | 2020 | 57 | 0.240 |
Why?
|
| South Carolina | 4 | 2020 | 2752 | 0.240 |
Why?
|
| Intensive Care Units | 2 | 1997 | 344 | 0.240 |
Why?
|
| Pharmacokinetics | 3 | 1995 | 14 | 0.240 |
Why?
|
| Psychotic Disorders | 1 | 2005 | 157 | 0.230 |
Why?
|
| Gaucher Disease | 4 | 1998 | 60 | 0.230 |
Why?
|
| Health Policy | 2 | 2012 | 221 | 0.230 |
Why?
|
| Models, Psychological | 1 | 2004 | 180 | 0.230 |
Why?
|
| Parkinson Disease, Secondary | 2 | 2000 | 4 | 0.220 |
Why?
|
| Tobacco Use Cessation | 1 | 2023 | 44 | 0.220 |
Why?
|
| Cluster Analysis | 4 | 2004 | 219 | 0.220 |
Why?
|
| Therapy, Computer-Assisted | 2 | 1997 | 57 | 0.220 |
Why?
|
| Naloxone | 1 | 2023 | 56 | 0.220 |
Why?
|
| Financing, Personal | 1 | 2003 | 17 | 0.220 |
Why?
|
| Ivermectin | 1 | 2022 | 12 | 0.210 |
Why?
|
| Adolescent Behavior | 1 | 2004 | 264 | 0.210 |
Why?
|
| Health Maintenance Organizations | 3 | 1999 | 22 | 0.200 |
Why?
|
| Common Data Elements | 1 | 2021 | 4 | 0.200 |
Why?
|
| Bayes Theorem | 3 | 2020 | 307 | 0.200 |
Why?
|
| Prostatic Neoplasms | 3 | 2019 | 778 | 0.200 |
Why?
|
| Electronics | 1 | 2021 | 25 | 0.200 |
Why?
|
| Narcotic Antagonists | 1 | 2023 | 184 | 0.200 |
Why?
|
| Acceleration | 1 | 2021 | 37 | 0.190 |
Why?
|
| Analysis of Variance | 7 | 2000 | 1040 | 0.190 |
Why?
|
| Decision Trees | 2 | 2019 | 74 | 0.190 |
Why?
|
| Health Behavior | 1 | 2004 | 458 | 0.190 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 166 | 0.190 |
Why?
|
| Health Promotion | 1 | 2004 | 407 | 0.190 |
Why?
|
| Contact Tracing | 1 | 2020 | 7 | 0.180 |
Why?
|
| Organizational Case Studies | 1 | 2020 | 53 | 0.180 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2020 | 13 | 0.180 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 18 | 0.180 |
Why?
|
| Public Health Practice | 1 | 2020 | 23 | 0.180 |
Why?
|
| Hospitalization | 2 | 2023 | 978 | 0.180 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 60 | 0.180 |
Why?
|
| Cooperative Behavior | 2 | 2016 | 235 | 0.180 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 26 | 0.180 |
Why?
|
| Self Care | 5 | 2014 | 253 | 0.180 |
Why?
|
| Nifedipine | 1 | 1999 | 40 | 0.170 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 83 | 0.170 |
Why?
|
| Amlodipine | 1 | 1999 | 31 | 0.170 |
Why?
|
| Prazosin | 1 | 1999 | 10 | 0.170 |
Why?
|
| Microbiota | 1 | 2021 | 80 | 0.170 |
Why?
|
| Insurance Claim Review | 1 | 1999 | 39 | 0.170 |
Why?
|
| Parkinsonian Disorders | 1 | 2000 | 43 | 0.170 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1999 | 32 | 0.170 |
Why?
|
| Meta-Analysis as Topic | 1 | 1999 | 57 | 0.170 |
Why?
|
| ROC Curve | 1 | 2020 | 392 | 0.170 |
Why?
|
| Calcium Channel Blockers | 1 | 1999 | 138 | 0.170 |
Why?
|
| Risk-Taking | 2 | 1997 | 210 | 0.160 |
Why?
|
| Psychometrics | 2 | 2000 | 514 | 0.160 |
Why?
|
| Social Isolation | 1 | 2019 | 40 | 0.160 |
Why?
|
| Pain Measurement | 3 | 2007 | 328 | 0.160 |
Why?
|
| Epidemiologic Studies | 1 | 1998 | 33 | 0.160 |
Why?
|
| Sampling Studies | 1 | 1998 | 80 | 0.160 |
Why?
|
| Clinical Coding | 1 | 2018 | 21 | 0.160 |
Why?
|
| Database Management Systems | 1 | 1998 | 25 | 0.150 |
Why?
|
| California | 5 | 2004 | 99 | 0.150 |
Why?
|
| Self-Assessment | 2 | 2000 | 69 | 0.150 |
Why?
|
| Informed Consent | 1 | 2019 | 127 | 0.150 |
Why?
|
| Random Allocation | 1 | 2019 | 442 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1999 | 239 | 0.150 |
Why?
|
| Fee-for-Service Plans | 1 | 1997 | 24 | 0.150 |
Why?
|
| Medical Futility | 1 | 1997 | 31 | 0.150 |
Why?
|
| Attitude of Health Personnel | 1 | 2000 | 442 | 0.140 |
Why?
|
| Philosophy, Medical | 1 | 1996 | 12 | 0.140 |
Why?
|
| Thrombophlebitis | 1 | 1997 | 47 | 0.140 |
Why?
|
| Models, Statistical | 4 | 2004 | 448 | 0.140 |
Why?
|
| Patient Care Planning | 1 | 2017 | 108 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 498 | 0.140 |
Why?
|
| Patient Compliance | 2 | 1999 | 402 | 0.140 |
Why?
|
| Hypermedia | 1 | 1996 | 2 | 0.130 |
Why?
|
| Adolescent | 6 | 2017 | 8912 | 0.130 |
Why?
|
| Point-of-Care Systems | 1 | 1997 | 115 | 0.130 |
Why?
|
| Medication Reconciliation | 1 | 2015 | 18 | 0.130 |
Why?
|
| Data Interpretation, Statistical | 4 | 2004 | 329 | 0.130 |
Why?
|
| Antirheumatic Agents | 2 | 2007 | 59 | 0.130 |
Why?
|
| Educational Status | 3 | 2005 | 273 | 0.130 |
Why?
|
| Antihypertensive Agents | 1 | 1999 | 498 | 0.130 |
Why?
|
| Multicenter Studies as Topic | 1 | 2016 | 186 | 0.130 |
Why?
|
| Workflow | 1 | 2016 | 100 | 0.130 |
Why?
|
| Treatment Failure | 1 | 1995 | 216 | 0.130 |
Why?
|
| Medicare | 1 | 1997 | 319 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1553 | 0.120 |
Why?
|
| Audiovisual Aids | 1 | 1994 | 20 | 0.120 |
Why?
|
| Physician's Role | 1 | 1995 | 116 | 0.120 |
Why?
|
| Health Services Research | 3 | 2000 | 209 | 0.120 |
Why?
|
| Quality Improvement | 2 | 2016 | 413 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 1536 | 0.110 |
Why?
|
| Critical Care | 2 | 1995 | 263 | 0.110 |
Why?
|
| Radiology Information Systems | 1 | 1993 | 21 | 0.110 |
Why?
|
| Ownership | 1 | 2013 | 18 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2023 | 7277 | 0.110 |
Why?
|
| Public Policy | 1 | 2013 | 71 | 0.110 |
Why?
|
| Multivariate Analysis | 3 | 2004 | 1046 | 0.110 |
Why?
|
| Total Quality Management | 2 | 2004 | 45 | 0.110 |
Why?
|
| Quality Control | 2 | 2007 | 81 | 0.100 |
Why?
|
| Competency-Based Education | 1 | 2012 | 32 | 0.100 |
Why?
|
| Education, Graduate | 1 | 2012 | 30 | 0.100 |
Why?
|
| Private Sector | 1 | 2012 | 19 | 0.100 |
Why?
|
| Information Management | 1 | 2012 | 23 | 0.100 |
Why?
|
| Reimbursement, Incentive | 1 | 2012 | 25 | 0.100 |
Why?
|
| Blood Coagulation Disorders | 1 | 1992 | 45 | 0.100 |
Why?
|
| Coronary Artery Bypass | 1 | 1993 | 218 | 0.100 |
Why?
|
| Wireless Technology | 1 | 2011 | 4 | 0.100 |
Why?
|
| Efficiency, Organizational | 1 | 2012 | 61 | 0.100 |
Why?
|
| Terminology as Topic | 2 | 2012 | 141 | 0.100 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 362 | 0.100 |
Why?
|
| Diffusion of Innovation | 1 | 2012 | 102 | 0.100 |
Why?
|
| Time Factors | 3 | 2022 | 4655 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 1993 | 319 | 0.090 |
Why?
|
| Double-Blind Method | 3 | 2023 | 1738 | 0.090 |
Why?
|
| Survival Analysis | 3 | 1997 | 714 | 0.090 |
Why?
|
| Heparin | 1 | 1992 | 205 | 0.090 |
Why?
|
| Medication Adherence | 1 | 2014 | 335 | 0.090 |
Why?
|
| Pharmaceutical Preparations | 1 | 1992 | 101 | 0.090 |
Why?
|
| Income | 2 | 2005 | 167 | 0.090 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1992 | 123 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2223 | 0.090 |
Why?
|
| Cognition | 2 | 2005 | 513 | 0.090 |
Why?
|
| Patient Selection | 3 | 1999 | 592 | 0.090 |
Why?
|
| Follow-Up Studies | 6 | 2004 | 3259 | 0.090 |
Why?
|
| Medication Systems, Hospital | 1 | 1989 | 19 | 0.090 |
Why?
|
| Software Design | 4 | 1993 | 18 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 2 | 2000 | 772 | 0.080 |
Why?
|
| Models, Biological | 2 | 1992 | 981 | 0.080 |
Why?
|
| Disease Notification | 1 | 2008 | 7 | 0.080 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2008 | 12 | 0.080 |
Why?
|
| Methotrexate | 2 | 2004 | 91 | 0.080 |
Why?
|
| Statistics, Nonparametric | 3 | 2001 | 306 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 2 | 1992 | 1026 | 0.080 |
Why?
|
| Multi-Institutional Systems | 1 | 2008 | 3 | 0.080 |
Why?
|
| Brain | 1 | 2019 | 2176 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 3 | 1999 | 219 | 0.080 |
Why?
|
| Family | 2 | 2000 | 293 | 0.080 |
Why?
|
| Programming Languages | 2 | 2003 | 16 | 0.080 |
Why?
|
| Young Adult | 2 | 2017 | 5717 | 0.070 |
Why?
|
| Prostate-Specific Antigen | 1 | 2008 | 138 | 0.070 |
Why?
|
| Geriatric Assessment | 1 | 2008 | 107 | 0.070 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2008 | 138 | 0.070 |
Why?
|
| Confidence Intervals | 2 | 1997 | 242 | 0.070 |
Why?
|
| Osteoarthritis | 1 | 2007 | 73 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2008 | 782 | 0.070 |
Why?
|
| Demography | 2 | 1998 | 279 | 0.070 |
Why?
|
| Sex Factors | 2 | 2000 | 1266 | 0.070 |
Why?
|
| Dementia | 1 | 2008 | 158 | 0.070 |
Why?
|
| Models, Econometric | 2 | 2003 | 26 | 0.070 |
Why?
|
| Forms and Records Control | 1 | 2006 | 16 | 0.070 |
Why?
|
| Medical Staff, Hospital | 1 | 2006 | 44 | 0.070 |
Why?
|
| Access to Information | 1 | 2006 | 21 | 0.070 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2006 | 33 | 0.070 |
Why?
|
| Feedback | 1 | 2006 | 90 | 0.070 |
Why?
|
| Equipment Failure | 1 | 2006 | 112 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2004 | 2279 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2000 | 1054 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2005 | 120 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1085 | 0.060 |
Why?
|
| Nuclear Warfare | 1 | 2005 | 11 | 0.060 |
Why?
|
| Research Design | 2 | 2019 | 729 | 0.060 |
Why?
|
| Hypertension | 1 | 2014 | 1535 | 0.060 |
Why?
|
| Cognition Disorders | 2 | 2004 | 342 | 0.060 |
Why?
|
| Hospital Mortality | 2 | 1997 | 384 | 0.060 |
Why?
|
| Videotape Recording | 1 | 2004 | 43 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 1993 | 1173 | 0.060 |
Why?
|
| Orthopedics | 1 | 2006 | 88 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2006 | 177 | 0.060 |
Why?
|
| Computer Graphics | 2 | 1995 | 37 | 0.060 |
Why?
|
| Monitoring, Physiologic | 1 | 2006 | 219 | 0.060 |
Why?
|
| Warfare | 1 | 2005 | 58 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2005 | 411 | 0.060 |
Why?
|
| Injury Severity Score | 1 | 2005 | 204 | 0.060 |
Why?
|
| Fluvoxamine | 1 | 2023 | 22 | 0.060 |
Why?
|
| Semantic Web | 1 | 2023 | 2 | 0.060 |
Why?
|
| Software Validation | 2 | 1993 | 4 | 0.060 |
Why?
|
| Monte Carlo Method | 2 | 2008 | 124 | 0.060 |
Why?
|
| Equipment Design | 1 | 2005 | 500 | 0.060 |
Why?
|
| Outpatients | 1 | 2023 | 127 | 0.050 |
Why?
|
| Automation | 1 | 2003 | 45 | 0.050 |
Why?
|
| Drug Repositioning | 1 | 2022 | 8 | 0.050 |
Why?
|
| Quality of Health Care | 2 | 2014 | 322 | 0.050 |
Why?
|
| Counseling | 1 | 2004 | 280 | 0.050 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2004 | 307 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2004 | 1851 | 0.050 |
Why?
|
| Aminoglycosides | 2 | 1992 | 54 | 0.050 |
Why?
|
| Anxiety | 1 | 2004 | 422 | 0.050 |
Why?
|
| Computer Simulation | 2 | 1997 | 706 | 0.050 |
Why?
|
| Mammography | 1 | 2023 | 310 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2001 | 737 | 0.050 |
Why?
|
| Quality Indicators, Health Care | 1 | 2001 | 136 | 0.050 |
Why?
|
| Research | 1 | 2002 | 214 | 0.050 |
Why?
|
| Health Level Seven | 1 | 2020 | 4 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 468 | 0.050 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2020 | 7 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2003 | 502 | 0.050 |
Why?
|
| Health Planning | 1 | 2000 | 23 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2022 | 340 | 0.040 |
Why?
|
| Patient Simulation | 1 | 2000 | 64 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 1993 | 567 | 0.040 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2020 | 53 | 0.040 |
Why?
|
| Pennsylvania | 1 | 1999 | 46 | 0.040 |
Why?
|
| Age Factors | 3 | 2016 | 1864 | 0.040 |
Why?
|
| Risk | 1 | 2001 | 563 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2004 | 931 | 0.040 |
Why?
|
| Los Angeles | 1 | 1999 | 30 | 0.040 |
Why?
|
| Personal Narratives as Topic | 1 | 2019 | 4 | 0.040 |
Why?
|
| Maryland | 1 | 1999 | 77 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2022 | 506 | 0.040 |
Why?
|
| Clozapine | 2 | 2004 | 46 | 0.040 |
Why?
|
| Selection Bias | 1 | 1998 | 23 | 0.040 |
Why?
|
| Research Personnel | 1 | 2019 | 83 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2000 | 880 | 0.040 |
Why?
|
| Students, Medical | 1 | 2000 | 210 | 0.040 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1997 | 21 | 0.040 |
Why?
|
| Akathisia, Drug-Induced | 1 | 1997 | 4 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2014 | 767 | 0.040 |
Why?
|
| Reimbursement Mechanisms | 1 | 1997 | 37 | 0.040 |
Why?
|
| Resource Allocation | 1 | 1997 | 35 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 1997 | 35 | 0.040 |
Why?
|
| Withholding Treatment | 1 | 1997 | 35 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2008 | 4848 | 0.040 |
Why?
|
| Patients | 1 | 1998 | 69 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 1998 | 546 | 0.040 |
Why?
|
| Postphlebitic Syndrome | 1 | 1997 | 1 | 0.040 |
Why?
|
| Value of Life | 1 | 1997 | 14 | 0.040 |
Why?
|
| Databases as Topic | 1 | 1997 | 49 | 0.040 |
Why?
|
| Prostatectomy | 1 | 1997 | 87 | 0.040 |
Why?
|
| Hospital Costs | 1 | 1997 | 117 | 0.040 |
Why?
|
| Attitude to Computers | 1 | 1997 | 38 | 0.030 |
Why?
|
| Sex Distribution | 1 | 1997 | 274 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2016 | 85 | 0.030 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1995 | 14 | 0.030 |
Why?
|
| APACHE | 1 | 1995 | 41 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1997 | 182 | 0.030 |
Why?
|
| Cost Savings | 1 | 2016 | 110 | 0.030 |
Why?
|
| Linear Models | 1 | 1997 | 521 | 0.030 |
Why?
|
| Hospitals, University | 1 | 1995 | 169 | 0.030 |
Why?
|
| Videodisc Recording | 1 | 1995 | 3 | 0.030 |
Why?
|
| Tape Recording | 1 | 1995 | 6 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 1995 | 193 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 1997 | 233 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 1996 | 174 | 0.030 |
Why?
|
| Hemorrhage | 1 | 1997 | 328 | 0.030 |
Why?
|
| Utah | 1 | 2014 | 27 | 0.030 |
Why?
|
| Glucosylceramidase | 1 | 1994 | 50 | 0.030 |
Why?
|
| Data Mining | 1 | 2014 | 45 | 0.030 |
Why?
|
| Logistic Models | 1 | 1997 | 1420 | 0.030 |
Why?
|
| United States Government Agencies | 1 | 2013 | 4 | 0.030 |
Why?
|
| Internal Medicine | 1 | 2014 | 118 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2014 | 152 | 0.030 |
Why?
|
| Genomics | 1 | 2014 | 168 | 0.030 |
Why?
|
| Physical Examination | 2 | 1991 | 152 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 286 | 0.030 |
Why?
|
| Data Display | 1 | 1993 | 17 | 0.030 |
Why?
|
| Urban Population | 1 | 2014 | 255 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 1993 | 61 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 1996 | 365 | 0.030 |
Why?
|
| Probability | 1 | 1993 | 245 | 0.030 |
Why?
|
| Societies, Scientific | 1 | 2012 | 18 | 0.030 |
Why?
|
| Computer-Assisted Instruction | 1 | 1993 | 74 | 0.030 |
Why?
|
| HIV Infections | 1 | 2000 | 791 | 0.030 |
Why?
|
| Whole Blood Coagulation Time | 1 | 1992 | 8 | 0.030 |
Why?
|
| Radiography | 1 | 1993 | 572 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 1993 | 1753 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2014 | 343 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 1995 | 1465 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1992 | 91 | 0.020 |
Why?
|
| Rural Population | 1 | 2014 | 398 | 0.020 |
Why?
|
| Hydroxychloroquine | 1 | 1990 | 14 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2016 | 659 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 1990 | 87 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1992 | 163 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 2334 | 0.020 |
Why?
|
| Thrombosis | 1 | 1992 | 218 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 1990 | 137 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1992 | 175 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 1991 | 190 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1997 | 1615 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2014 | 3705 | 0.020 |
Why?
|
| Theophylline | 1 | 1989 | 22 | 0.020 |
Why?
|
| Aspirin | 1 | 1990 | 295 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1993 | 1745 | 0.020 |
Why?
|
| Ranitidine | 1 | 1989 | 16 | 0.020 |
Why?
|
| Vitamin E | 1 | 1989 | 55 | 0.020 |
Why?
|
| Bilirubin | 1 | 1989 | 51 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2008 | 51 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 1992 | 2455 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2008 | 50 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 1451 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2008 | 223 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2008 | 223 | 0.020 |
Why?
|
| Infant, Premature | 1 | 1989 | 284 | 0.020 |
Why?
|
| Seizures | 1 | 2008 | 279 | 0.020 |
Why?
|
| Recurrence | 1 | 2008 | 948 | 0.020 |
Why?
|
| Altruism | 1 | 2005 | 24 | 0.020 |
Why?
|
| Child | 2 | 1994 | 6405 | 0.020 |
Why?
|
| Erectile Dysfunction | 1 | 2005 | 22 | 0.020 |
Why?
|
| Observation | 1 | 2005 | 30 | 0.020 |
Why?
|
| Liver | 1 | 1990 | 1118 | 0.020 |
Why?
|
| Colonic Diseases | 1 | 2005 | 36 | 0.020 |
Why?
|
| Hostility | 1 | 2004 | 19 | 0.020 |
Why?
|
| Urinary Incontinence | 1 | 2005 | 67 | 0.020 |
Why?
|
| Caregivers | 1 | 2008 | 365 | 0.010 |
Why?
|
| Aggression | 1 | 2004 | 98 | 0.010 |
Why?
|
| Principal Component Analysis | 1 | 2004 | 55 | 0.010 |
Why?
|
| Haloperidol | 1 | 2004 | 95 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 2005 | 183 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 1330 | 0.010 |
Why?
|
| Mood Disorders | 1 | 2004 | 132 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2005 | 346 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 581 | 0.010 |
Why?
|
| Benchmarking | 1 | 2000 | 91 | 0.010 |
Why?
|
| Risk Factors | 2 | 2000 | 5731 | 0.010 |
Why?
|
| Ventricular Fibrillation | 1 | 1999 | 85 | 0.010 |
Why?
|
| Heart Arrest | 1 | 1999 | 113 | 0.010 |
Why?
|
| Tachycardia, Ventricular | 1 | 1999 | 153 | 0.010 |
Why?
|
| Registries | 1 | 2000 | 733 | 0.010 |
Why?
|
| Cohort Studies | 1 | 1999 | 2358 | 0.010 |
Why?
|
| Ventilators, Mechanical | 1 | 1991 | 13 | 0.010 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 1990 | 17 | 0.010 |
Why?
|
| Hospital Information Systems | 1 | 1991 | 44 | 0.010 |
Why?
|
| Patient Admission | 1 | 1991 | 99 | 0.010 |
Why?
|
| Canada | 1 | 1990 | 267 | 0.010 |
Why?
|
| Carboxyhemoglobin | 1 | 1989 | 2 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1989 | 47 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 1991 | 281 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1990 | 649 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1989 | 120 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1989 | 289 | 0.000 |
Why?
|